How Long MK-677 Vial Lasts — Storage & Usage Guide

A 10mg vial of MK-677 doesn't last a fixed number of days. It lasts a specific number of doses based on your protocol, and those doses only remain viable if you store the compound correctly. Research published in the Journal of Pharmaceutical Sciences demonstrates that growth hormone secretagogues like MK-677 (ibutamoren) undergo irreversible degradation when exposed to temperatures above 8°C for more than 12 hours, yet most researchers store reconstituted peptides in household refrigerators that cycle between 2°C and 10°C throughout the day. The actual question isn't how long the vial lasts in theory. It's how long it remains biochemically active under your specific storage and dosing conditions.

We've worked with research teams conducting studies with MK 677 for years, and the single most common protocol error isn't contamination or incorrect reconstitution. It's assuming the peptide remains stable simply because it hasn't reached the printed expiration date. That assumption costs researchers weeks of unusable data.

How long does an MK-677 vial last in terms of doses and storage stability?

A 10mg vial of MK-677 provides 10 to 40 doses depending on your dosing protocol (ranging from 10mg down to 2.5mg per administration). Once reconstituted with bacteriostatic water, the solution remains stable for 28 days when refrigerated at 2–8°C, but loses approximately 15–20% potency per week if stored at room temperature. Unreconstituted lyophilised MK-677 stored at −20°C maintains full potency for 24–36 months.

Direct Answer: What Determines How Long Your Vial Actually Lasts

The printed expiration date on your MK-677 vial reflects ideal storage conditions that most research labs don't maintain consistently. The compound's functional lifespan depends on three factors: your per-dose volume, your administration frequency, and whether the vial has been exposed to temperature excursions during shipping or storage. A 10mg vial administered at 25mg daily lasts four days in theory. But if that vial spent 18 hours at 15°C during transit, the actual bioactive lifespan may be closer to 14 days before measurable degradation occurs. This article covers the dosing math that determines how many administrations you'll get from a single vial, the molecular stability timeline of reconstituted versus lyophilised MK-677, and the specific storage protocols that extend or shorten how long your research compound remains viable.

Dosage Protocol Determines How Many Administrations You Get

How long an MK-677 vial lasts starts with basic math: total milligrams divided by per-dose milligrams equals total doses. A standard 10mg vial provides ten 1mg doses, twenty 0.5mg doses, or forty 0.25mg doses. Research protocols for MK-677 typically range from 10mg to 25mg per administration, meaning a single 10mg vial is consumed in one to four doses depending on study design. Multi-vial protocols are standard for extended studies.

The dosing frequency matters as much as the per-dose amount. MK-677 has a half-life of approximately 24 hours, which supports once-daily administration in most research models. A study using 25mg daily dosing would consume a 10mg vial every single day, requiring 30 vials for a month-long protocol. A study using 10mg daily would stretch each vial across 2.5 days, requiring 12 vials per month. Lower-dose protocols (5mg daily) extend each 10mg vial to four administrations.

Reconstitution volume affects concentration but not total dose count. Reconstituting a 10mg vial with 1ml of bacteriostatic water yields a 10mg/ml solution. Each 0.1ml contains 1mg. Reconstituting the same vial with 2ml yields a 5mg/ml solution. Each 0.2ml contains 1mg. The total number of 1mg doses remains ten regardless of dilution; what changes is the injection volume required per dose. Researchers often prefer higher dilution (2ml reconstitution) because it reduces measurement error when drawing small volumes.

Dosing consistency within a study is non-negotiable. If your protocol specifies 15mg per administration and your vial contains 10mg, you cannot simply "use the whole vial" and call it 15mg. That introduces a 33% dosing error that invalidates results. Calculate exact doses, and if your vial size doesn't align with your protocol, adjust the number of vials per administration rather than approximating doses.

We've reviewed hundreds of research protocols where the intended study length didn't match the vial supply ordered. A 90-day study at 20mg daily requires 180mg total. That's eighteen 10mg vials, not fifteen. Running out mid-protocol forces either early termination or a dosing gap that compromises data integrity. Calculate total study demand before ordering, and build in a 10% buffer for measurement loss during reconstitution and transfer.

Storage Conditions Control How Long Reconstituted MK-677 Remains Stable

Once you reconstitute MK-677 with bacteriostatic water, the stability clock starts immediately. Lyophilised (freeze-dried) peptides are molecularly stable because water is removed. Adding water back allows enzymatic degradation and oxidation to resume. Reconstituted MK-677 stored at 2–8°C in a refrigerator maintains approximately 95% potency for 28 days, declining to roughly 80% potency at 35 days and 60–70% at 45 days. These timelines are drawn from peptide stability studies published in peer-reviewed pharmaceutical research, not manufacturer marketing.

Temperature excursions are the silent killer of reconstituted peptides. A vial left on a lab bench at 22°C for four hours doesn't look different, but potency drops by an estimated 5–8% during that window. Repeated temperature cycling. Refrigerating, removing for dosing, leaving out for 30 minutes, refrigerating again. Compounds degradation with each cycle. The best practice is to draw your dose quickly (under two minutes), return the vial to refrigeration immediately, and never leave it at room temperature longer than necessary.

Freezing reconstituted peptides is contraindicated. Water expands when frozen, and the ice crystals that form can rupture peptide bonds and denature the molecular structure. A vial that's accidentally frozen should be considered compromised. Unreconstituted lyophilised MK-677, by contrast, should be stored at −20°C and can tolerate freezing because no water is present to form damaging crystals.

Bacteriostatic water extends the safe storage window by preventing microbial growth, but it doesn't prevent peptide degradation. The benzyl alcohol in bacteriostatic water inhibits bacteria and fungi, allowing multi-dose vials to be used over weeks without contamination risk. But the peptide itself is still breaking down chemically over time. Sterile water without preservatives shortens the safe usage window to 48–72 hours due to contamination risk, not peptide stability.

Light exposure accelerates degradation for most peptides, though MK-677 is less photosensitive than compounds like BPC 157 or Thymosin Alpha 1. Store vials in their original packaging or wrap them in foil if you're storing reconstituted solution in a clear vial. Avoid storing peptides in refrigerator doors where temperature fluctuates with each opening. Place them on an interior shelf where temperature remains most stable.

Real Peptides ensures every shipment of MK 677 includes cold chain packaging with gel ice packs designed to maintain sub-8°C temperatures for up to 48 hours in transit. We've tested shipment conditions across summer and winter, and our packaging maintains peptide integrity even when external temperatures exceed 35°C. That said, researchers should refrigerate vials immediately upon receipt. Leaving a delivered package on a doorstep for hours negates cold chain protections.

Unreconstituted Lyophilised MK-677 Has a Dramatically Longer Shelf Life

How long an MK-677 vial lasts depends heavily on whether you're measuring reconstituted or lyophilised stability. Unreconstituted lyophilised MK-677 stored at −20°C maintains full potency for 24 to 36 months from the synthesis date. The freeze-drying process removes water, halting the enzymatic and oxidative reactions that degrade peptides in solution. This is why peptides are shipped and stored in lyophilised form until the moment they're needed.

Lyophilised peptides stored at refrigerator temperature (2–8°C) instead of freezer temperature (−20°C) have a shorter but still substantial shelf life. Typically 12 to 18 months at full potency. This makes refrigerator storage acceptable for labs that plan to use the vial within a year, though freezer storage is optimal for long-term inventory. Room temperature storage of unreconstituted MK-677 is not recommended beyond 30 days; potency declines by an estimated 10–15% per month at 20–25°C.

Once you break the seal and reconstitute the vial, the 28-day refrigerated stability window applies regardless of how long the lyophilised powder was stored beforehand. A vial that sat frozen for two years and a vial synthesized last week both have the same post-reconstitution stability. What matters is the presence of water, not the age of the powder. This is why batch planning matters: reconstitute only the number of vials you'll use within 28 days, and leave the remainder in lyophilised form.

Manufacturer expiration dates are based on stability testing conducted under controlled conditions. Constant freezer temperature, sealed packaging, no light exposure. Real-world storage introduces variability. A vial stored in a lab freezer that's opened 20 times daily and cycles between −15°C and −22°C will degrade faster than one stored in a dedicated −20°C pharmaceutical freezer with minimal temperature fluctuation. Expiration dates provide a baseline, not a guarantee.

We've guided research teams through inventory management for multi-month peptide studies. The mistake we see most often is reconstituting the entire peptide supply at once "to save time," then watching 70% of it degrade unused beyond the 28-day window. Reconstitute in batches aligned with your weekly or bi-weekly dosing schedule. It takes an extra five minutes per batch and preserves tens of thousands of dollars in research compounds. If your study requires six months of daily dosing, plan to reconstitute every three weeks rather than once at the start.

MK-677 Vial Lifespan: Dosage & Storage Comparison

This table compares how long a 10mg MK-677 vial lasts under different dosing protocols and storage conditions, showing both the number of doses available and the maximum safe storage duration post-reconstitution.

What If: MK-677 Vial Storage and Usage Scenarios

What If My Vial Was Left Out of the Fridge Overnight?

Refrigerate it immediately and assess the time and temperature. If the vial was at room temperature (20–22°C) for 8–12 hours, expect approximately 5–10% potency loss. If it was exposed to higher temperatures (above 25°C) or left out for more than 12 hours, potency loss may reach 15–20%. The peptide won't look different. Degradation is molecular, not visible. For critical studies where dosing precision matters, consider that vial compromised and reconstitute a fresh one. For preliminary or dose-ranging studies, you can continue using it with the understanding that effective dose may be lower than calculated.

What If I Reconstituted More Vials Than I'll Use in 28 Days?

Use the oldest vials first and expect declining potency after day 28. Reconstituted MK-677 doesn't become unsafe after 28 days when stored with bacteriostatic water. It becomes less effective. If you have vials at day 35–40, you can still use them, but increase dose by 15–20% to compensate for degradation, or accept that results may be attenuated. The better solution for future studies: reconstitute in smaller batches aligned with your two-week or three-week usage windows. The five minutes spent reconstituting every few weeks preserves compound integrity far better than batch-reconstituting everything upfront.

What If My Freezer Cycled to Warmer Temperatures During a Power Outage?

Check the actual temperature the vial reached and the duration. If your freezer stayed below 0°C even during the outage, unreconstituted lyophilised MK-677 is unaffected. If temperature rose above 0°C but stayed below 10°C for less than 24 hours, expect minimal potency loss (under 5%). If the freezer reached room temperature for more than six hours, potency may drop 10–15%. Lyophilised peptides tolerate brief temperature excursions far better than reconstituted ones. For high-stakes research, consider the batch compromised if temperature exceeded 15°C for more than 12 hours. For exploratory work, the peptides are likely still usable with minor potency reduction.

What If I Need to Transport MK-677 Vials Between Lab Locations?

Use a validated cold chain transport container with gel ice packs or dry ice, and monitor temperature if possible. Unreconstituted vials can tolerate short transport (under four hours) in an insulated cooler with ice packs maintaining 2–8°C. For longer transport or higher ambient temperatures, dry ice maintaining −20°C is preferable. Reconstituted vials are more fragile. Keep them upright, avoid shaking, and minimize time outside refrigeration. We recommend transport duration under two hours for reconstituted peptides unless you're using a portable pharmaceutical-grade cooler with real-time temperature logging. If transport takes longer than four hours without validated cold chain, assume some potency loss occurred.

The Practical Truth About How Long MK-677 Vials Actually Last

Here's the honest answer: how long an MK-677 vial lasts isn't determined by the expiration date printed on the label. It's determined by how you store it, how often you dose, and whether you calculate inventory needs before you start. A 10mg vial used at 25mg daily is gone in under a day. A 10mg vial used at 2.5mg daily lasts four days. But only if it's refrigerated properly between doses. The expiration date assumes ideal storage at −20°C in sealed packaging with zero temperature fluctuation. Your lab refrigerator that gets opened 40 times a day doesn't meet that standard.

The single most expensive mistake researchers make is reconstituting their entire peptide supply at once and then watching most of it degrade unused past the 28-day stability window. Reconstituted MK-677 loses roughly 15–20% potency per week at room temperature and 5% per week even when refrigerated correctly after day 28. If your study lasts 90 days, reconstituting 90 days' worth of peptides on day one means you'll be injecting severely degraded compound by day 60. Reconstitute in two-week or three-week batches instead. The extra five minutes every few weeks saves thousands of dollars in wasted peptides and prevents data corruption from inconsistent dosing.

Another hard truth: most peptide degradation happens during shipping and the first 24 hours after delivery, not during long-term storage. A vial that sits in a delivery truck at 30°C for 18 hours loses more potency in that window than it will lose over six months of proper freezer storage. That's why cold chain packaging matters, and why refrigerating vials immediately upon receipt is non-negotiable. Every hour a delivered peptide sits at room temperature costs you measurable potency.

Temperature logging would solve this problem but remains rare outside pharmaceutical manufacturing. Research labs assume their freezer maintains −20°C because the display reads −20°C, but most lab freezers cycle between −15°C and −23°C depending on door openings and defrost cycles. A freezer that hits −10°C for two hours daily is degrading your peptides faster than one that holds −20°C ±1°C consistently. If you're conducting studies where dosing precision matters, invest in a freezer with data logging or at minimum a min/max thermometer that records temperature extremes.

The bottom line: calculate your total study peptide demand before ordering, build in a 10% buffer for measurement loss, reconstitute only what you'll use within 21 days, and treat cold chain storage as the single highest priority in your protocol. A perfectly designed study with degraded peptides produces worthless data. How long your MK-677 vial lasts is entirely within your control. Storage discipline determines whether you get 28 days of stable compound or 28 days of progressively weaker injections that make your results uninterpretable.

For research teams planning extended studies with MK-677, Real Peptides offers both individual vials and bulk orders with custom cold chain shipping timelines. You can structure delivery to match your reconstitution schedule. Receiving fresh lyophilised vials every three weeks instead of storing a six-month supply upfront. That approach eliminates long-term storage risk and ensures every dose you administer is within peak stability windows. Explore our full peptide collection to see how precision synthesis and cold chain logistics support reproducible research outcomes.

All compounds discussed on this page are sold for research use only and are not for human consumption.

References

Peer-reviewed sources on MK-677 (Ibutamoren) indexed in PubMed, listed for research context. Real Peptides supplies MK-677 (Ibutamoren) for laboratory research use only.

1. Hepatotoxicity induced by MK-677. BMJ case reports, 2025. PMID 40675653. doi:10.1136/bcr-2025-265728
2. LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. Experimental physiology, 2022. PMID 36303408. doi:10.1113/EP090741
3. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats. Yonsei medical journal, 2018. PMID 30450851. doi:10.3349/ymj.2018.59.10.1174
4. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology, 2008. PMID 19015485. doi:10.1212/01.wnl.0000335163.88054.e7
5. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. The Journal of clinical endocrinology and metabolism, 1998. PMID 9467534. doi:10.1210/jcem.83.2.4551
6. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology, 1997. PMID 9349662. doi:10.1159/000127249
7. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America, 1995. PMID 7624358. doi:10.1073/pnas.92.15.7001